Loading…

The endocrinological component and signaling pathways associated to cardiac hypertrophy

Although myocardial growth corresponds to an adaptive response to maintain cardiac contractile function, the cardiac hypertrophy is a condition that occurs in many cardiovascular diseases and typically precedes the onset of heart failure. Different endocrine factors such as thyroid hormones, insulin...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and cellular endocrinology 2020-12, Vol.518, p.110972-110972, Article 110972
Main Authors: Takano, Ana Paula Cremasco, Senger, Nathalia, Barreto-Chaves, Maria Luiza M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c373t-8f36fa55b65bbe71f7ae533cae39702e84d3218adaad104947eb2041b766ed3c3
cites cdi_FETCH-LOGICAL-c373t-8f36fa55b65bbe71f7ae533cae39702e84d3218adaad104947eb2041b766ed3c3
container_end_page 110972
container_issue
container_start_page 110972
container_title Molecular and cellular endocrinology
container_volume 518
creator Takano, Ana Paula Cremasco
Senger, Nathalia
Barreto-Chaves, Maria Luiza M.
description Although myocardial growth corresponds to an adaptive response to maintain cardiac contractile function, the cardiac hypertrophy is a condition that occurs in many cardiovascular diseases and typically precedes the onset of heart failure. Different endocrine factors such as thyroid hormones, insulin, insulin-like growth factor 1 (IGF-1), angiotensin II (Ang II), endothelin (ET-1), catecholamines, estrogen, among others represent important stimuli to cardiomyocyte hypertrophy. Thus, numerous endocrine disorders manifested as changes in the local environment or multiple organ systems are especially important in the context of progression from cardiac hypertrophy to heart failure. Based on that information, this review summarizes experimental findings regarding the influence of such hormones upon signalling pathways associated with cardiac hypertrophy. Understanding mechanisms through which hormones differentially regulate cardiac hypertrophy could open ways to obtain therapeutic approaches that contribute to prevent or delay the onset of heart failure related to endocrine diseases. •Endocrine stimuli can lead to increase of cardiomyocyte volume inducing to a cardiac hypertrophic phenotype.•The development of cardiac hypertrophy by endocrine factors occurs by activation of distinct cellular signaling or multiple interconnected signaling pathways.•Here, some endocrine factors and their signaling pathways responsible for physiological or pathological cardiac hypertrophy are addressed.
doi_str_mv 10.1016/j.mce.2020.110972
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2432863563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303720720302720</els_id><sourcerecordid>2432863563</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-8f36fa55b65bbe71f7ae533cae39702e84d3218adaad104947eb2041b766ed3c3</originalsourceid><addsrcrecordid>eNp9kEtLw0AUhQdRsFZ_gLtZukmdR5JJcSXFFxTcVFwONzM3zZR0Js6kSv69KXXt6nDhfBfOR8gtZwvOeHm_W-wNLgQT083ZUokzMuOVElnFCnVOZkwymSnB1CW5SmnHGFOFqGbkc9MiRW-Dic6HLmydgY6asO-DRz9Q8JYmt_XQOb-lPQztD4yJQkrBOBjQ0iFQA9E6MLQde4xDDH07XpOLBrqEN385Jx_PT5vVa7Z-f3lbPa4zI5UcsqqRZQNFUZdFXaPijQIspDSAcqmYwCq3UvAKLIDlLF_mCmvBcl6rskQrjZyTu9PfPoavA6ZB710y2HXgMRySFrkUVSmLUk5VfqqaGFKK2Og-uj3EUXOmjxL1Tk8S9VGiPkmcmIcTg9OGb4dRJ-PQG7Quohm0De4f-hcSEHuE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2432863563</pqid></control><display><type>article</type><title>The endocrinological component and signaling pathways associated to cardiac hypertrophy</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Takano, Ana Paula Cremasco ; Senger, Nathalia ; Barreto-Chaves, Maria Luiza M.</creator><creatorcontrib>Takano, Ana Paula Cremasco ; Senger, Nathalia ; Barreto-Chaves, Maria Luiza M.</creatorcontrib><description>Although myocardial growth corresponds to an adaptive response to maintain cardiac contractile function, the cardiac hypertrophy is a condition that occurs in many cardiovascular diseases and typically precedes the onset of heart failure. Different endocrine factors such as thyroid hormones, insulin, insulin-like growth factor 1 (IGF-1), angiotensin II (Ang II), endothelin (ET-1), catecholamines, estrogen, among others represent important stimuli to cardiomyocyte hypertrophy. Thus, numerous endocrine disorders manifested as changes in the local environment or multiple organ systems are especially important in the context of progression from cardiac hypertrophy to heart failure. Based on that information, this review summarizes experimental findings regarding the influence of such hormones upon signalling pathways associated with cardiac hypertrophy. Understanding mechanisms through which hormones differentially regulate cardiac hypertrophy could open ways to obtain therapeutic approaches that contribute to prevent or delay the onset of heart failure related to endocrine diseases. •Endocrine stimuli can lead to increase of cardiomyocyte volume inducing to a cardiac hypertrophic phenotype.•The development of cardiac hypertrophy by endocrine factors occurs by activation of distinct cellular signaling or multiple interconnected signaling pathways.•Here, some endocrine factors and their signaling pathways responsible for physiological or pathological cardiac hypertrophy are addressed.</description><identifier>ISSN: 0303-7207</identifier><identifier>EISSN: 1872-8057</identifier><identifier>DOI: 10.1016/j.mce.2020.110972</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Cardiomyocyte ; Hormones ; Molecular mechanisms ; Signalling pathways</subject><ispartof>Molecular and cellular endocrinology, 2020-12, Vol.518, p.110972-110972, Article 110972</ispartof><rights>2020 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-8f36fa55b65bbe71f7ae533cae39702e84d3218adaad104947eb2041b766ed3c3</citedby><cites>FETCH-LOGICAL-c373t-8f36fa55b65bbe71f7ae533cae39702e84d3218adaad104947eb2041b766ed3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Takano, Ana Paula Cremasco</creatorcontrib><creatorcontrib>Senger, Nathalia</creatorcontrib><creatorcontrib>Barreto-Chaves, Maria Luiza M.</creatorcontrib><title>The endocrinological component and signaling pathways associated to cardiac hypertrophy</title><title>Molecular and cellular endocrinology</title><description>Although myocardial growth corresponds to an adaptive response to maintain cardiac contractile function, the cardiac hypertrophy is a condition that occurs in many cardiovascular diseases and typically precedes the onset of heart failure. Different endocrine factors such as thyroid hormones, insulin, insulin-like growth factor 1 (IGF-1), angiotensin II (Ang II), endothelin (ET-1), catecholamines, estrogen, among others represent important stimuli to cardiomyocyte hypertrophy. Thus, numerous endocrine disorders manifested as changes in the local environment or multiple organ systems are especially important in the context of progression from cardiac hypertrophy to heart failure. Based on that information, this review summarizes experimental findings regarding the influence of such hormones upon signalling pathways associated with cardiac hypertrophy. Understanding mechanisms through which hormones differentially regulate cardiac hypertrophy could open ways to obtain therapeutic approaches that contribute to prevent or delay the onset of heart failure related to endocrine diseases. •Endocrine stimuli can lead to increase of cardiomyocyte volume inducing to a cardiac hypertrophic phenotype.•The development of cardiac hypertrophy by endocrine factors occurs by activation of distinct cellular signaling or multiple interconnected signaling pathways.•Here, some endocrine factors and their signaling pathways responsible for physiological or pathological cardiac hypertrophy are addressed.</description><subject>Cardiomyocyte</subject><subject>Hormones</subject><subject>Molecular mechanisms</subject><subject>Signalling pathways</subject><issn>0303-7207</issn><issn>1872-8057</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLw0AUhQdRsFZ_gLtZukmdR5JJcSXFFxTcVFwONzM3zZR0Js6kSv69KXXt6nDhfBfOR8gtZwvOeHm_W-wNLgQT083ZUokzMuOVElnFCnVOZkwymSnB1CW5SmnHGFOFqGbkc9MiRW-Dic6HLmydgY6asO-DRz9Q8JYmt_XQOb-lPQztD4yJQkrBOBjQ0iFQA9E6MLQde4xDDH07XpOLBrqEN385Jx_PT5vVa7Z-f3lbPa4zI5UcsqqRZQNFUZdFXaPijQIspDSAcqmYwCq3UvAKLIDlLF_mCmvBcl6rskQrjZyTu9PfPoavA6ZB710y2HXgMRySFrkUVSmLUk5VfqqaGFKK2Og-uj3EUXOmjxL1Tk8S9VGiPkmcmIcTg9OGb4dRJ-PQG7Quohm0De4f-hcSEHuE</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Takano, Ana Paula Cremasco</creator><creator>Senger, Nathalia</creator><creator>Barreto-Chaves, Maria Luiza M.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20201201</creationdate><title>The endocrinological component and signaling pathways associated to cardiac hypertrophy</title><author>Takano, Ana Paula Cremasco ; Senger, Nathalia ; Barreto-Chaves, Maria Luiza M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-8f36fa55b65bbe71f7ae533cae39702e84d3218adaad104947eb2041b766ed3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cardiomyocyte</topic><topic>Hormones</topic><topic>Molecular mechanisms</topic><topic>Signalling pathways</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takano, Ana Paula Cremasco</creatorcontrib><creatorcontrib>Senger, Nathalia</creatorcontrib><creatorcontrib>Barreto-Chaves, Maria Luiza M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takano, Ana Paula Cremasco</au><au>Senger, Nathalia</au><au>Barreto-Chaves, Maria Luiza M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The endocrinological component and signaling pathways associated to cardiac hypertrophy</atitle><jtitle>Molecular and cellular endocrinology</jtitle><date>2020-12-01</date><risdate>2020</risdate><volume>518</volume><spage>110972</spage><epage>110972</epage><pages>110972-110972</pages><artnum>110972</artnum><issn>0303-7207</issn><eissn>1872-8057</eissn><abstract>Although myocardial growth corresponds to an adaptive response to maintain cardiac contractile function, the cardiac hypertrophy is a condition that occurs in many cardiovascular diseases and typically precedes the onset of heart failure. Different endocrine factors such as thyroid hormones, insulin, insulin-like growth factor 1 (IGF-1), angiotensin II (Ang II), endothelin (ET-1), catecholamines, estrogen, among others represent important stimuli to cardiomyocyte hypertrophy. Thus, numerous endocrine disorders manifested as changes in the local environment or multiple organ systems are especially important in the context of progression from cardiac hypertrophy to heart failure. Based on that information, this review summarizes experimental findings regarding the influence of such hormones upon signalling pathways associated with cardiac hypertrophy. Understanding mechanisms through which hormones differentially regulate cardiac hypertrophy could open ways to obtain therapeutic approaches that contribute to prevent or delay the onset of heart failure related to endocrine diseases. •Endocrine stimuli can lead to increase of cardiomyocyte volume inducing to a cardiac hypertrophic phenotype.•The development of cardiac hypertrophy by endocrine factors occurs by activation of distinct cellular signaling or multiple interconnected signaling pathways.•Here, some endocrine factors and their signaling pathways responsible for physiological or pathological cardiac hypertrophy are addressed.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.mce.2020.110972</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0303-7207
ispartof Molecular and cellular endocrinology, 2020-12, Vol.518, p.110972-110972, Article 110972
issn 0303-7207
1872-8057
language eng
recordid cdi_proquest_miscellaneous_2432863563
source ScienceDirect Freedom Collection 2022-2024
subjects Cardiomyocyte
Hormones
Molecular mechanisms
Signalling pathways
title The endocrinological component and signaling pathways associated to cardiac hypertrophy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T16%3A36%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20endocrinological%20component%20and%20signaling%20pathways%20associated%20to%20cardiac%20hypertrophy&rft.jtitle=Molecular%20and%20cellular%20endocrinology&rft.au=Takano,%20Ana%20Paula%20Cremasco&rft.date=2020-12-01&rft.volume=518&rft.spage=110972&rft.epage=110972&rft.pages=110972-110972&rft.artnum=110972&rft.issn=0303-7207&rft.eissn=1872-8057&rft_id=info:doi/10.1016/j.mce.2020.110972&rft_dat=%3Cproquest_cross%3E2432863563%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c373t-8f36fa55b65bbe71f7ae533cae39702e84d3218adaad104947eb2041b766ed3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2432863563&rft_id=info:pmid/&rfr_iscdi=true